Clinical trial Recruiting at 1 site Interventional Ages 5 to 16

Bubble PEP plus Segmental Breathing versus Incentive Spirometry for children with pleural effusion

Official title: Effect of Bubble Positive Expiratory Pressure and Segmental Breathing Versus Incentive Spirometry on Lung Expansion and Dyspnea in Children With Pleural Effusion

Run by Riphah International University · NCT07248774 · Data updated 2026-11-12

This trial will test whether bubble positive expiratory pressure with segmental breathing helps children aged 5–16 with pleural effusion breathe better than incentive spirometry.

Quick facts

Study typeInterventional
Ages5 Years to 16 Years
SexAll
Enrollment40 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedOctober 28, 2025
Main results expectedJanuary 5, 2026
Study endsJanuary 15, 2026
Registry record updatedNovember 25, 2025
Trial IDNCT07248774 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 5–16 with pleural effusion or hydrothorax who have had a thoracic drainage system in place for at least 24 hours and no other coexisting illnesses.

Probably not a fit

Patients with other pulmonary pathologies, chest trauma, pneumothorax, hemothorax, chylothorax, significant chest pain, musculoskeletal chest deformities, or comorbid causes of effusion are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized clinical trial enrolling 40 pediatric patients aged 5–16 at hospitals in Lahore who have pleural effusion. Participants are randomly assigned to receive either Bubble PEP with segmental breathing or incentive spirometry, with both groups also receiving conventional chest physiotherapy and mobility. Outcomes measured before and after the intervention include lung expansion on chest X-ray, dyspnea using the Pediatric Dyspnea Scale, chest expansion by tape measure, oxygen saturation (SpO₂), and respiratory rate. The study tests whether the low-cost Bubble PEP approach can be an effective alternative to mechanical incentive spirometers in this population.

Why it matters

Potential benefit: If successful, the approach could offer a low-cost, effective way to improve lung expansion and breathing in children with pleural effusion.

How similar studies have gone: PEP techniques and incentive spirometry have shown benefits for airway clearance and lung expansion in other populations, but direct comparisons in pediatric pleural effusion are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 5 to 16.
* Suffering from Pleural effusion or hydrothorax.
* Thoracic drainage system in situ for 24 hours.
* Either gender will be included.
* Patients without any other co-existing illness.

Exclusion Criteria:

* Any other pulmonary pathology that does not fit the diagnostic criteria of Pleural Effusion.
* Participants with unbearable chest pain, chylothorax, hemothorax, pneumothorax, chest trauma or rib fracture.
* Participants with other comorbidities leading to pleural effusion.
* Patients who have chest musculoskeletal deformities.

Where it's running

  • The Children Hospital and University of Child Health Sciences
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.